Display options
Cite
Leiter A, Doucette J, Krege S, et al. Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma. Bladder Cancer. 2016;2(3):341-349doi: 10.3233/BLC-160047.
Leiter, A., Doucette, J., Krege, S., Lin, C. C., Hahn, N., Ecke, T., Sonpavde, G., Bamias, A., Oh, W. K., & Galsky, M. D. (2016). Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma. Bladder cancer (Amsterdam, Netherlands), 2(3), 341-349. https://doi.org/10.3233/BLC-160047
Leiter, Amanda, et al. "Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma." Bladder cancer (Amsterdam, Netherlands) vol. 2,3 (2016): 341-349. doi: https://doi.org/10.3233/BLC-160047
Leiter A, Doucette J, Krege S, Lin CC, Hahn N, Ecke T, Sonpavde G, Bamias A, Oh WK, Galsky MD. Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma. Bladder Cancer. 2016 Jul 27;2(3):341-349. doi: 10.3233/BLC-160047. PMID: 27500201; PMCID: PMC4969712.
Copy Download .nbib Format: NLM
Share it on

Bladder Cancer. 2016 Jul 27;2(3):341-349. doi: 10.3233/BLC-160047.

Obesity and Outcomes in Patients with Metastatic Urothelial Carcinoma.

Bladder cancer (Amsterdam, Netherlands)

Amanda Leiter, John Doucette, Susan Krege, Chia-Chi Lin, Noah Hahn, Thorsten Ecke, Guru Sonpavde, Aristotle Bamias, William K Oh, Matthew D Galsky

Affiliations

  1. Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  2. Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  3. Urologische Klinik, Alexianer Krefeld GmbH, Krefeld, Germany.
  4. Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  5. Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  6. HELIOS Hospital, Bad Saarow, Germany.
  7. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
  8. University of Athens, Athens, Greece.

PMID: 27500201 PMCID: PMC4969712 DOI: 10.3233/BLC-160047

[No abstract available.]

Keywords: BMI; BSA; Metastatic bladder cancer; body mass index; body surface area; metastatic urothelial cancer; obesity

References

  1. Annu Rev Med. 2010;61:301-16 - PubMed
  2. Am J Med. 2004 Apr 1;116(7):435-42 - PubMed
  3. Int J Urol. 2014 Nov;21(11):1106-12 - PubMed
  4. Cancer. 2007 Nov 15;110(10):2339-46 - PubMed
  5. J Urol. 2013 Aug;190(2):480-6 - PubMed
  6. Am J Clin Nutr. 2005 Jun;81(6):1330-4 - PubMed
  7. Cancer. 2007 Oct 1;110(7):1478-84 - PubMed
  8. Oncologist. 2011;16(1):71-81 - PubMed
  9. J Clin Oncol. 2004 Jan 15;22(2):220-8 - PubMed
  10. Clin Genitourin Cancer. 2013 Sep;11(3):346-52 - PubMed
  11. N Engl J Med. 2003 Apr 24;348(17):1625-38 - PubMed
  12. Oncol Rep. 2006 Dec;16(6):1381-8 - PubMed
  13. Clin Genitourin Cancer. 2014 Oct;12(5):384-93 - PubMed
  14. Cancer. 2010 Jun 1;116(11):2596-603 - PubMed
  15. PLoS One. 2015 Mar 24;10(3):e0119313 - PubMed
  16. Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1214-21 - PubMed
  17. BJU Int. 2013 Feb;111(2):249-55 - PubMed
  18. Cancer. 2006 Mar 15;106(6):1269-75 - PubMed
  19. J Clin Oncol. 2011 Apr 20;29(12):1525-30 - PubMed
  20. Urol Int. 2009;82(4):432-9 - PubMed
  21. Lancet. 2011 Aug 27;378(9793):815-25 - PubMed
  22. Lancet. 2014 Aug 30;384(9945):766-81 - PubMed
  23. Urol Oncol. 2011 Sep-Oct;29(5):476-86 - PubMed
  24. Oncologist. 2011;16(11):1565-71 - PubMed
  25. J Urol. 2007 Jan;177(1):84-9; discussion 89 - PubMed
  26. Asian Pac J Cancer Prev. 2013;14(5):3117-21 - PubMed

Publication Types